Guardion Health Sciences, Inc. (GHSI)
NASDAQ: GHSI · IEX Real-Time Price · USD
8.51
+0.01 (0.12%)
At close: May 17, 2024, 4:00 PM
8.66
+0.15 (1.76%)
After-hours: May 17, 2024, 7:55 PM EDT

Guardion Health Sciences Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for GHSI.

Analyst Consensus: Hold
Target Low Average Median High
Price n/a n/a n/a n/a
Change n/a n/a n/a n/a

Analyst Ratings

According to 1 stock analyst, the rating for GHSI is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating Feb '24Mar '24Apr '24May '24
Strong Buy 0000
Buy 0000
Hold 1111
Sell 0000
Strong Sell 0000
Total 1111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Hold
Downgrades
n/a
Hold Downgrades n/a n/a Feb 2, 2024
Ascendiant Capital
Ascendiant Capital
Strong Buy
Initiates
$38
Strong Buy Initiates $38 +340.66% Jul 18, 2022
Maxim Group
Maxim Group
Strong Buy
Initiates
$30
Strong Buy Initiates $30 +252.53% Mar 8, 2022
More Analyst Ratings

Financial Forecast

Revenue This Year
13.72M
from 12.25M
Increased by 12.01%
Revenue Next Year
15.09M
from 13.72M
Increased by 10.00%
EPS This Year
-2.45
from 0.12
EPS Next Year
-1.04
from -2.45
Year 2019202020212022202320242025
Revenue
902.94K1.89M7.23M11.05M12.25M13.72M15.09M
Revenue Growth
-4.16%109.30%282.74%52.77%10.85%12.01%10.00%
EPS
-89.50-30.00-52.23-14.150.12-2.45-1.04
EPS Growth
-------
No. Analysts -----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025
High 14.1M 15.5M
Avg 13.7M 15.1M
Low 13.2M 14.5M

Revenue Growth

Revenue Growth 20242025
High
15.3%
13.2%
Avg
12.0%
10.0%
Low
7.6%
5.7%

EPS Forecast

EPS 20242025
High -2.52 -1.07
Avg -2.45 -1.04
Low -2.35 -1.00

EPS Growth

EPS Growth 20242025
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.